Search
+

    Gainers & Losers: Adani Ports among 6 stocks that dominated the day

    1/7

    Newsmakers of D-Street

    Amid strong global cues and sold foreign fund inflows, Sensex ended 578 points higher, while the Nifty50 ended above the 17,800 mark. Nifty Pharma was the biggest sectoral gainer with a rally of over 3 per cent. Midcaps outperformed as India VIX eased over 5 per cent.


    Here are a handful of stocks that were in focus today:

    Spotlight Wire
    Advanced Enzyme
    2/7

    Advanced Enzyme

    Shares of Advanced Enzyme Technologies ended 9.8 per cent higher at Rs 293.05 after Nalanda India Equity Fund bought 29,11,630 shares in the company.

    TIMESOFINDIA.COM
    Crompton Greaves
    3/7

    Crompton Greaves

    Shares of electrical equipment manufacturer Crompton Greaves ended 5.7 per cent higher at Rs 415.20 after the company approved the sale of a 6 per cent stake in its subsidiary Butterfly Gandhimathi Appliances via an offer for sale (OFS).

    Bombay Dyeing
    4/7

    Bombay Dyeing

    Shares of textile company Bombay Dyeing ended about 4 per cent higher at Rs 104.40 after the company said its board of directors would consider a proposal for raising funds by issue of equity shares.

    Agencies
    Ircon
    5/7

    Ircon

    Shares of Ircon international rose over 6 per cent in Tuesday’s trade after the railway firm received a work order worth Rs 256 crore of detailed engineering and project management consultancy services for the development of rail infrastructure for Ananta OCP of Jagannath Area at Talcher, from Mahanadi Coalfields. The stock ended about 3 per cent higher at Rs 41.50.

    IANS
    Adani Ports
    6/7

    Adani Ports

    The stock of Adani Ports gained up to 3 per cent before ending the day at Rs 969.40. The West Bengal government has awarded a greenfield deep sea Tajpur port project to APSEZ at an investment of Rs 25,000 crore.

    IANS
    Natco Pharma
    7/7

    Natco Pharma

    Natco Pharma gained up to 3.5 per cent to hit a day's high at Rs 660. The drugmaker said it received a court order allowing it to launch the insecticide Chlorantraniliprole (CTPR) and its formulations.

    Agencies
    The Economic Times
    X
    User